IBM introduced two new quantum chips in latest step forward The Nighthawk chip increases circuit complexity by 30% over its predecessor Loon is IBM’s first chip to demonstrate full fault-tolerant ...
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback